We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Progyny Inc (PGNY) USD0.0001

Sell:$16.60 Buy:$16.61 Change: $0.005 (0.03%)
NASDAQ:0.09%
Market closed |  Prices as at close on 8 November 2024 | Switch to live prices |
Sell:$16.60
Buy:$16.61
Change: $0.005 (0.03%)
Market closed |  Prices as at close on 8 November 2024 | Switch to live prices |
Sell:$16.60
Buy:$16.61
Change: $0.005 (0.03%)
Market closed |  Prices as at close on 8 November 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Contact details

Address:
1359 Broadway
NEW YORK
10018
United States
Telephone:
+1 (212) 8883124
Website:
https://www.progyny.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PGNY
ISIN:
US74340E1038
Market cap:
$1.48 billion
Shares in issue:
90.28 million
Sector:
Managed Health Care
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • David Schlanger
    Executive Chairman of the Board
  • Michael Sturmer
    President
  • Peter Anevski
    Chief Executive Officer, Director
  • Mark Livingston
    Chief Financial Officer
  • Allison Swartz
    Executive Vice President, General Counsel, Company Secretary
  • Steven Leist
    Chief Technology Officer
  • Katie Higgins
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.